Paper published in a journal (Scientific congresses and symposiums)
Ph Ib/II study of BKM120 plus trastuzumab in patients with trastuzumab-resistant HER2+ advanced breast cancer
Pistilli, Barbara; Urruticoechea, Ander; Chan Stephen et al.
2012In Annals of Oncology, 23 (supplément 9), p. 116
Peer Reviewed verified by ORBi
 

Files


Full Text
ESMO 2012 abstract.pdf
Publisher postprint (7.31 MB)
Request a copy
Annexes
ESMO 2012 - présentation.pdf
Publisher postprint (455.43 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Pistilli, Barbara;  Macerata Hospital, Macerata, Italy
Urruticoechea, Ander;  Catalan Institute of Oncology, Barcelona, Spain
Chan Stephen;  Nottingham University Hospital, Nottingham, UK
Han, Hyo Sook;  Moffit Cancer Center, Tampa, FL
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Kong, Anthony;  Oxford University Hospitals NHS Trust, Oxford, UK
Ru, Qinhua;  Novartis Oncology, Florham Park, NJ
Ruquet, Sophie;  Novartis Oncology, Paris, France
Sternberg, David;  Novartis Oncology, Florham Park, NJ
Saura, Cristina;  Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Language :
English
Title :
Ph Ib/II study of BKM120 plus trastuzumab in patients with trastuzumab-resistant HER2+ advanced breast cancer
Publication date :
2012
Event name :
37th ESMO Congress
Event organizer :
ESMO
Event place :
Vienna, Austria
Event date :
28 September - 2 October 2012
Audience :
International
Journal title :
Annals of Oncology
ISSN :
0923-7534
eISSN :
1569-8041
Publisher :
Oxford University Press, London, United Kingdom
Volume :
23
Issue :
supplément 9
Pages :
ix116
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 15 October 2013

Statistics


Number of views
87 (7 by ULiège)
Number of downloads
2 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi